Collectively, these four distinct molecular subsets (NF2 loss, mTORC1 hyperactive, FH-deficient and ALK translocation) accounted for 55% of our uRCC cohort (Fig. 4a). The gene discussed is NF2; the disease is Unclassified Renal Cell Carcinoma.